Cargando…
Baricitinib for COVID-19: a suitable treatment? – Authors' reply
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271155/ https://www.ncbi.nlm.nih.gov/pubmed/32251639 http://dx.doi.org/10.1016/S1473-3099(20)30270-X |
| _version_ | 1783542035725156352 |
|---|---|
| author | Richardson, Peter J Corbellino, Mario Stebbing, Justin |
| author_facet | Richardson, Peter J Corbellino, Mario Stebbing, Justin |
| author_sort | Richardson, Peter J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7271155 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72711552020-06-05 Baricitinib for COVID-19: a suitable treatment? – Authors' reply Richardson, Peter J Corbellino, Mario Stebbing, Justin Lancet Infect Dis Article Elsevier Ltd. 2020-09 2020-04-03 /pmc/articles/PMC7271155/ /pubmed/32251639 http://dx.doi.org/10.1016/S1473-3099(20)30270-X Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Richardson, Peter J Corbellino, Mario Stebbing, Justin Baricitinib for COVID-19: a suitable treatment? – Authors' reply |
| title | Baricitinib for COVID-19: a suitable treatment? – Authors' reply |
| title_full | Baricitinib for COVID-19: a suitable treatment? – Authors' reply |
| title_fullStr | Baricitinib for COVID-19: a suitable treatment? – Authors' reply |
| title_full_unstemmed | Baricitinib for COVID-19: a suitable treatment? – Authors' reply |
| title_short | Baricitinib for COVID-19: a suitable treatment? – Authors' reply |
| title_sort | baricitinib for covid-19: a suitable treatment? – authors' reply |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271155/ https://www.ncbi.nlm.nih.gov/pubmed/32251639 http://dx.doi.org/10.1016/S1473-3099(20)30270-X |
| work_keys_str_mv | AT richardsonpeterj baricitinibforcovid19asuitabletreatmentauthorsreply AT corbellinomario baricitinibforcovid19asuitabletreatmentauthorsreply AT stebbingjustin baricitinibforcovid19asuitabletreatmentauthorsreply |